Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2023
Q4
Sell
-963
Closed -$259K 81
2023
Q3
$259K Buy
+963
New +$240K 0.18% 102
2023
Q2
Sell
-1,060
Closed -$256K 89
2023
Q1
$256K Sell
1,060
-55
-5% -$13.5K 0.17% 107
2022
Q4
$293K Buy
+1,115
New +$299K 0.2% 104

Other funds holding AMGN

Corrado Advisors's AMGN Position: Q4 2023 in Review

Corrado Advisors sold out of Amgen (AMGN) in Q4 2023, closing a stake of 963 shares — an estimated $259K sold.

Corrado Advisors first reported a position in AMGN in Q4 2022 and held it in 3 quarters. The position peaked at $293K in Q4 2022. 2,714 funds tracked by Wall St. Rank hold AMGN as of Q4 2023.

  • Corrado Advisors reported no remaining Amgen position as of Q4 2023 after selling out during the quarter.
  • Corrado Advisors sold 963 Amgen shares in Q4 2023, an estimated $259K.
  • Corrado Advisors first reported a position in Amgen in Q4 2022 and held it in 3 quarters.
  • Corrado Advisors's Amgen position peaked at $293K in Q4 2022.
  • 2,714 funds tracked by Wall St. Rank held Amgen as of Q4 2023.

Based on Corrado Advisors's 13F filing for Q4 2023, filed 1 Feb 2024.